Treatment sequence with gilteritinib and allogeneic haematopoietic stem cell transplantation in relapsed/refractory FMS-like tyrosine kinase 3 (FLT3)-mutated acute myeloid leukaemia patients: A multicentre real-world study.

Kunadt D, Zukunft S, Röllig C, Metzelder S, Burchert A, Wagner-Drouet E, Kriege O, Schliemann C, Stelljes M, Ronnacker J, Bethge W, Weller JF, Steffen B, Bug G, Kouidri K, Baldus C, Fransecky L, Sala E, Platzbecker U, Metzeler K, Kayser S, Hilgendorf I, Hochhaus A, Brümmendorf TH, Jost E, Doleschall AD, Schroeder T, Kaivers J, Kordelas L, Holtick U, Unglaub JM, Sauer T, Jäger PS, Kobbe G, Stauffer E, Tischer J, Herold T, Steiner N, Nachbaur D, Kröger N, Frietsch JJ, Kraus S, Einsele H, Hänel M, Schaffrath J, Krüger W, Brandenburg A, Holderried TAW, Reinhardt L, Maulhardt M, Thiede C, Bornhäuser M, Schetelig J, Middeke JM, Stölzel F, German Cooperative Transplant Study Group and Study Alliance Leukemia (SAL)

Open source

DOI: 10.1111/bjh.70735
Published: 2026 Aug 18
Container: British journal of haematology
Publisher: Not recorded
Open access: unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1111/bjh.70735,
  title = {Treatment sequence with gilteritinib and allogeneic haematopoietic stem cell transplantation in relapsed/refractory FMS-like tyrosine kinase 3 (FLT3)-mutated acute myeloid leukaemia patients: A multicentre real-world study.},
  author = {Kunadt D and Zukunft S and Röllig C and Metzelder S and Burchert A and Wagner-Drouet E and Kriege O and Schliemann C and Stelljes M and Ronnacker J and Bethge W and Weller JF and Steffen B and Bug G and Kouidri K and Baldus C and Fransecky L and Sala E and Platzbecker U and Metzeler K and Kayser S and Hilgendorf I and Hochhaus A and Brümmendorf TH and Jost E and Doleschall AD and Schroeder T and Kaivers J and Kordelas L and Holtick U and Unglaub JM and Sauer T and Jäger PS and Kobbe G and Stauffer E and Tischer J and Herold T and Steiner N and Nachbaur D and Kröger N and Frietsch JJ and Kraus S and Einsele H and Hänel M and Schaffrath J and Krüger W and Brandenburg A and Holderried TAW and Reinhardt L and Maulhardt M and Thiede C and Bornhäuser M and Schetelig J and Middeke JM and Stölzel F and German Cooperative Transplant Study Group and Study Alliance Leukemia (SAL)},
  year = {2026},
  journal = {British journal of haematology},
  doi = {10.1111/bjh.70735},
  url = {https://doi.org/10.1111/bjh.70735}
}

RIS

TY  - JOUR
TI  - Treatment sequence with gilteritinib and allogeneic haematopoietic stem cell transplantation in relapsed/refractory FMS-like tyrosine kinase 3 (FLT3)-mutated acute myeloid leukaemia patients: A multicentre real-world study.
AU  - Kunadt D
AU  - Zukunft S
AU  - Röllig C
AU  - Metzelder S
AU  - Burchert A
AU  - Wagner-Drouet E
AU  - Kriege O
AU  - Schliemann C
AU  - Stelljes M
AU  - Ronnacker J
AU  - Bethge W
AU  - Weller JF
AU  - Steffen B
AU  - Bug G
AU  - Kouidri K
AU  - Baldus C
AU  - Fransecky L
AU  - Sala E
AU  - Platzbecker U
AU  - Metzeler K
AU  - Kayser S
AU  - Hilgendorf I
AU  - Hochhaus A
AU  - Brümmendorf TH
AU  - Jost E
AU  - Doleschall AD
AU  - Schroeder T
AU  - Kaivers J
AU  - Kordelas L
AU  - Holtick U
AU  - Unglaub JM
AU  - Sauer T
AU  - Jäger PS
AU  - Kobbe G
AU  - Stauffer E
AU  - Tischer J
AU  - Herold T
AU  - Steiner N
AU  - Nachbaur D
AU  - Kröger N
AU  - Frietsch JJ
AU  - Kraus S
AU  - Einsele H
AU  - Hänel M
AU  - Schaffrath J
AU  - Krüger W
AU  - Brandenburg A
AU  - Holderried TAW
AU  - Reinhardt L
AU  - Maulhardt M
AU  - Thiede C
AU  - Bornhäuser M
AU  - Schetelig J
AU  - Middeke JM
AU  - Stölzel F
AU  - German Cooperative Transplant Study Group and Study Alliance Leukemia (SAL)
PY  - 2026
JO  - British journal of haematology
DO  - 10.1111/bjh.70735
UR  - https://doi.org/10.1111/bjh.70735
ER  -

APA

D, K., S, Z., C, R., S, M., A, B., E, W., O, K., C, S., M, S., J, R., W, B., JF, W., B, S., G, B., K, K., C, B., L, F., E, S., U, P., K, M., S, K., I, H., A, H., TH, B., E, J., AD, D., T, S., J, K., L, K., U, H., JM, U., T, S., PS, J., G, K., E, S., J, T., T, H., N, S., D, N., N, K., JJ, F., S, K., H, E., M, H., J, S., W, K., A, B., TAW, H., L, R., M, M., C, T., M, B., J, S., JM, M., F, S., & (SAL), G. C. T. S. G. A. S. A. L. (2026). Treatment sequence with gilteritinib and allogeneic haematopoietic stem cell transplantation in relapsed/refractory FMS-like tyrosine kinase 3 (FLT3)-mutated acute myeloid leukaemia patients: A multicentre real-world study.. British journal of haematology. https://doi.org/10.1111/bjh.70735

Source records

pubmed · retrieved 2026-09-25T23:37:10.915Z